ArticleBritish journal of haematology2020

Early experience using salvage radiotherapy for relapsed/refractory non-Hodgkin lymphomas after CD19 chimeric antigen receptor (CAR) T cell therapy.

Brandon S Imber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.